Home > Insider Trading > Filing (0001209191-22-020333)

Filing Details

Accession Number:: 0001209191-22-020333
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-21 18:20:27
Reporting Period:: 2022-03-17

Accepted Time:: 2022-03-21 18:20:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1802768	Royalty Pharma Plc	RPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1016835	B Rory Riggs	C/O Royalty Pharma Plc 110 E. 59Th Street New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares	Acquisiton	2022-03-17	4,897	$0.00	597,645	No	4	J	Direct
Class A Ordinary Shares	Acquisiton	2022-03-17	64,067	$0.00	661,712	No	4	J	Direct
Class A Ordinary Shares	Disposition	2022-03-17	229,626	$0.00	72,348	No	4	J	Indirect	By New Ventures Select
Class A Ordinary Shares	Disposition	2022-03-17	1,075,178	$0.00	40,560	No	4	J	Indirect	By New Ventures I LLC
Class A Ordinary Shares	Disposition	2022-03-17	531,684	$0.00	141,368	No	4	J	Indirect	By New Ventures III LLC
Class A Ordinary Shares	Disposition	2022-03-18	46,803	$39.38	25,545	No	4	S	Indirect	By New Ventures Select
Class A Ordinary Shares	Disposition	2022-03-18	26,238	$39.38	14,322	No	4	S	Indirect	By New Ventures I LLC
Class A Ordinary Shares	Disposition	2022-03-18	56,181	$39.77	85,187	No	4	S	Indirect	By New Ventures III LLC
Class A Ordinary Shares	Disposition	2022-03-21	25,545	$39.05	0	No	4	S	Indirect	By New Ventures Select
Class A Ordinary Shares	Disposition	2022-03-21	14,322	$39.05	0	No	4	S	Indirect	By New Ventures I LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	J	Direct
No	4	J	Indirect	By New Ventures Select
No	4	J	Indirect	By New Ventures I LLC
No	4	J	Indirect	By New Ventures III LLC
No	4	S	Indirect	By New Ventures Select
No	4	S	Indirect	By New Ventures I LLC
No	4	S	Indirect	By New Ventures III LLC
No	4	S	Indirect	By New Ventures Select
No	4	S	Indirect	By New Ventures I LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Ordinary Shares	15,000	Indirect	By Spouse

Footnotes

Pro rata distribution from New Ventures Select, of which the Reporting Person has voting and investment control.
Pro rata distribution from a limited liability company of which the Reporting Person is a member.
Pro rata distribution from New Ventures I LLC, of which the Reporting Person has voting and investment control.
New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.
New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.
New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.20 to $39.70 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.21 to $39.71 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.71 to $39.30 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.